Literature DB >> 17185788

The role of genes and environment in the etiology of PCOS.

Evanthia Diamanti-Kandarakis1, Helen Kandarakis, Richard S Legro.   

Abstract

Both genes and the environment contribute to PCOS. Obesity, exacerbated by poor dietary choices and physical inactivity, worsens PCOS in susceptible individuals. The role of other environmental modifiers such as infectious agents or toxins are speculative. Phenotype confusion has characterized genetic studies of PCOS. Although several loci have been proposed as PCOS genes including CYP11A, the insulin gene, the follistatin gene, and a region near the insulin receptor, the evidence supporting linkage is not overwhelming. The strongest case can be made for the region near the insulin receptor gene (but not involving this gene), as it has been identified in two separate studies, and perhaps most importantly has not yet been refuted by larger studies. However, the responsible gene at chromosome 19p13.3 remains to be identified. To date, no gene has been identified that causes or contributes substantially to the development of a PCOS phenotype.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185788     DOI: 10.1385/ENDO:30:1:19

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  51 in total

Review 1.  The TDT and other family-based tests for linkage disequilibrium and association.

Authors:  R S Spielman; W J Ewens
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

2.  Role of allelic variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in moderate-to-severe insulin resistance of women with polycystic ovary syndrome.

Authors:  S A El Mkadem; C Lautier; F Macari; N Molinari; P Lefèbvre; E Renard; J C Gris; G Cros; J P Daurès; J Bringer; M F White; F Grigorescu
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

3.  Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome.

Authors:  David A Ehrmann; Peter E H Schwarz; Manami Hara; Xu Tang; Yukio Horikawa; Jacqueline Imperial; Graeme I Bell; Nancy J Cox
Journal:  J Clin Endocrinol Metab       Date:  2002-04       Impact factor: 5.958

Review 4.  Contribution of pathogens in human obesity.

Authors:  Nikhil V Dhurandhar
Journal:  Drug News Perspect       Date:  2004-06

5.  Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome.

Authors:  L J Moran; M Noakes; P M Clifton; L Tomlinson; C Galletly; R J Norman
Journal:  J Clin Endocrinol Metab       Date:  2003-02       Impact factor: 5.958

6.  Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

Authors:  R S Legro; D Driscoll; J F Strauss; J Fox; A Dunaif
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Evidence for a single gene effect causing polycystic ovaries and male pattern baldness.

Authors:  A H Carey; K L Chan; F Short; D White; R Williamson; S Franks
Journal:  Clin Endocrinol (Oxf)       Date:  1993-06       Impact factor: 3.478

8.  Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.

Authors:  R Kaushal; N Parchure; G Bano; J-C Kaski; S S Nussey
Journal:  Clin Endocrinol (Oxf)       Date:  2004-03       Impact factor: 3.478

9.  Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys.

Authors:  Nikhil V Dhurandhar; Leah D Whigham; David H Abbott; Nancy J Schultz-Darken; Barbara A Israel; Steven M Bradley; Joseph W Kemnitz; David B Allison; Richard L Atkinson
Journal:  J Nutr       Date:  2002-10       Impact factor: 4.798

10.  Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

Authors:  L Ibáñez; N Potau; I Francois; F de Zegher
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

View more
  47 in total

1.  Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.

Authors:  Uche Anadu Ndefo; Angie Eaton; Monica Robinson Green
Journal:  P T       Date:  2013-06

2.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

3.  Association of single nucleotide polymorphisms in the RAB5B gene 3'UTR region with polycystic ovary syndrome in Chinese Han women.

Authors:  Jia Yu; Caifei Ding; Siqi Guan; Chenye Wang
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

Review 4.  Polycystic ovary syndrome: do endocrine-disrupting chemicals play a role?

Authors:  Emily S Barrett; Marissa Sobolewski
Journal:  Semin Reprod Med       Date:  2014-04-08       Impact factor: 1.303

Review 5.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

6.  Lack of Association of Vitamin D Receptor FokI (rs10735810) (C/T) and BsmI (rs1544410) (A/G) Genetic Variations with Polycystic Ovary Syndrome Risk: a Case-control Study from Iranian Azeri Turkish Women.

Authors:  Morteza Bagheri; Isa Abdi Rad; Nima Hosseini Jazani; Fariba Nanbakhsh
Journal:  Maedica (Buchar)       Date:  2012-12

7.  Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.

Authors:  Meng-Xue Zheng; Yan Li; Rong Hu; Fei-Miao Wang; Xiao-Mei Zhang; Bing Guan
Journal:  J Assist Reprod Genet       Date:  2016-01-06       Impact factor: 3.412

8.  The plasminogen activator inhibitor-1 (PAI-1) gene -844 A/G and -675 4G/5G promoter polymorphism significantly influences plasma PAI-1 levels in women with polycystic ovary syndrome.

Authors:  Sun Lin; Zhang Huiya; Liu Bo; Wei Wei; Guan Yongmei
Journal:  Endocrine       Date:  2009-10-24       Impact factor: 3.633

9.  Digit ratios do not serve as anatomical evidence of prenatal androgen exposure in clinical phenotypes of polycystic ovary syndrome.

Authors:  Marla E Lujan; Terri G Bloski; Donna R Chizen; Denis C Lehotay; Roger A Pierson
Journal:  Hum Reprod       Date:  2009-10-24       Impact factor: 6.918

Review 10.  Sheep models of polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.